Entia Biosciences, Inc. (ERGO)
OTCMKTS
· Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
At close: May 2, 2025
Entia Biosciences Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2016 | FY 2015 | FY 2014 | FY 2013 | FY 2012 | 2007 - 2011 |
|---|---|---|---|---|---|---|
Period Ending | Dec '16 Dec 31, 2016 | Dec '15 Dec 31, 2015 | Dec '14 Dec 31, 2014 | Dec '13 Dec 31, 2013 | Dec '12 Dec 31, 2012 | 2007 - 2011 |
| Revenue | 0.27 | 0.35 | 0.66 | 0.31 | 0.37 | Upgrade
|
| Revenue Growth (YoY) | -23.48% | -47.14% | 108.53% | -14.77% | -8.45% | Upgrade
|
| Cost of Revenue | 0.09 | 0.13 | 0.25 | 0.13 | 0.11 | Upgrade
|
| Gross Profit | 0.17 | 0.22 | 0.41 | 0.18 | 0.26 | Upgrade
|
| Selling, General & Admin | 1.34 | 2.13 | 2.18 | 2.87 | 1.34 | Upgrade
|
| Operating Expenses | 1.34 | 2.13 | 2.18 | 2.87 | 1.34 | Upgrade
|
| Operating Income | -1.17 | -1.92 | -1.77 | -2.68 | -1.08 | Upgrade
|
| Interest Expense | -0.08 | -0.17 | -0.44 | -0.14 | -0.26 | Upgrade
|
| Interest & Investment Income | - | - | - | 0.01 | 0 | Upgrade
|
| Other Non Operating Income (Expenses) | -0.01 | -0.04 | 0.01 | - | - | Upgrade
|
| EBT Excluding Unusual Items | -1.26 | -2.12 | -2.2 | -2.82 | -1.34 | Upgrade
|
| Asset Writedown | -0.05 | -0.11 | -0.03 | -0.29 | - | Upgrade
|
| Legal Settlements | -0.09 | - | - | - | - | Upgrade
|
| Other Unusual Items | 0 | -0.03 | -0.07 | - | 0.08 | Upgrade
|
| Pretax Income | -1.4 | -2.26 | -2.3 | -3.1 | -1.26 | Upgrade
|
| Net Income | -1.4 | -2.26 | -2.3 | -3.1 | -1.26 | Upgrade
|
| Preferred Dividends & Other Adjustments | - | - | - | 0.09 | 0.02 | Upgrade
|
| Net Income to Common | -1.4 | -2.26 | -2.3 | -3.19 | -1.29 | Upgrade
|
| Shares Outstanding (Basic) | 28 | 24 | 9 | 8 | 7 | Upgrade
|
| Shares Outstanding (Diluted) | 28 | 24 | 9 | 8 | 7 | Upgrade
|
| Shares Change (YoY) | 15.84% | 157.24% | 25.34% | 3.22% | 16.62% | Upgrade
|
| EPS (Basic) | -0.05 | -0.09 | -0.24 | -0.42 | -0.18 | Upgrade
|
| EPS (Diluted) | -0.05 | -0.09 | -0.24 | -0.42 | -0.18 | Upgrade
|
| Free Cash Flow | -0.72 | -0.54 | -0.68 | -0.82 | -0.33 | Upgrade
|
| Free Cash Flow Per Share | -0.03 | -0.02 | -0.07 | -0.11 | -0.04 | Upgrade
|
| Gross Margin | 65.53% | 62.24% | 62.60% | 58.34% | 70.90% | Upgrade
|
| Operating Margin | -439.75% | -552.29% | -269.82% | -851.98% | -292.65% | Upgrade
|
| Profit Margin | -525.79% | -651.48% | -349.91% | -1014.29% | -348.13% | Upgrade
|
| Free Cash Flow Margin | -269.38% | -156.99% | -104.35% | -260.30% | -89.84% | Upgrade
|
| EBITDA | -1.15 | -1.88 | -1.73 | -2.65 | -1.06 | Upgrade
|
| EBITDA Margin | - | - | -264.02% | - | -286.82% | Upgrade
|
| D&A For EBITDA | 0.02 | 0.03 | 0.04 | 0.04 | 0.02 | Upgrade
|
| EBIT | -1.17 | -1.92 | -1.77 | -2.68 | -1.08 | Upgrade
|
| EBIT Margin | - | - | -269.82% | - | -292.65% | Upgrade
|
| Advertising Expenses | 0.09 | 0.13 | 0.13 | 0.17 | 0.04 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.